Full-Time

Financial Analyst

Posted on 5/9/2025

IDEXX

IDEXX

5,001-10,000 employees

Diagnostic products for pet health

No salary listed

Junior, Mid

Company Does Not Provide H1B Sponsorship

Portland, ME, USA

Hybrid position with a requirement of 8 days in-office per month.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Power BI
SAP Products
Financial analysis
Tableau
Data Analysis
Excel/Numbers/Sheets
Financial Modeling
Requirements
  • Bachelor's degree in Finance, Accounting, Economics, Mathematics, Statistics, or equivalent combination of education and experience.
  • 1-3 years of experience in financial analysis, corporate finance, or related field.
  • Previous financial modeling experience.
  • Experience with SAP or other high-end ERP systems.
  • Experience with EPM systems (e.g., Anaplan, OneStream, Oracle Planning).
  • Experience working with large datasets and visualization/BI tools (e.g., Tableau, Power BI, SAP Analytics Cloud, Alteryx).
  • Exceptional analytical and critical thinking skills with strong attention to detail.
  • Strong Excel skills and proficiency in Microsoft Office suite.
  • Ability to translate complex financial data into clear, actionable insights.
  • Effective communication skills for collaborating with both financial and non-financial stakeholders.
  • Self-motivated with the ability to work both independently and as part of a team.
  • Drive to learn, grow, and thrive in a fast-paced environment.
Responsibilities
  • Assist in analyzing company-wide revenue growth and margin expansion, identifying trends and opportunities that inform executive decision-making.
  • Support our budgeting, forecasting, and reporting cycles, helping to deliver key insights that influence business decisions across the organization.
  • Create compelling financial reports and presentations that translate complex data into actionable business intelligence.
  • Collaborate with Finance teams from various Lines of Business and Functions to understand their contributions to overall company performance and integrate their insights into corporate financial reporting.
  • Support the development of financial models used by senior finance leaders for strategic decision-making.
  • Identify opportunities to enhance planning, analysis, and reporting processes.
  • Assist with month-end and quarter-end processes including account reconciliations and performance analysis.

IDEXX focuses on improving the health and well-being of pets, people, and livestock through a variety of diagnostic and information technology products and services. Their offerings include in-clinic diagnostic tests, laboratory services, telemedicine consultations, and practice management software, all designed to help veterinarians provide better medical care and improve the efficiency of their practices. IDEXX also develops diagnostic tests for the production animal industry and ensures the safety of drinking water and milk. What sets IDEXX apart from its competitors is its extensive global reach, serving customers in over 175 countries, and its commitment to enhancing pet healthcare, which is a rapidly growing market. The company's goal is to raise the standard of care for pets and livestock while ensuring safe drinking water for billions of people.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Westbrook, Maine

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising pet ownership boosts demand for IDEXX's diagnostic products.
  • Global veterinary diagnostics market expansion offers growth opportunities for IDEXX.
  • IDEXX's focus on sustainability aligns with industry trends and corporate responsibility goals.

What critics are saying

  • Increased competition from Zoetis and Heska may impact IDEXX's market share.
  • Rapid technological advancements require significant R&D investment, affecting profit margins.
  • Economic instability in Europe and Asia could reduce spending on veterinary services.

What makes IDEXX unique

  • IDEXX's Catalyst Platform offers real-time cortisol testing for canine endocrine disorders.
  • Procyte One analyzer uses advanced flow cytometry laser technology for precise diagnostics.
  • IDEXX's SpringBoard program provides free educational resources for veterinary residents.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Mental Health Support

Pet Insurance

Employee Stock Purchase Plan

Volunteer Paid Days Off

Company News

PR Newswire
Jun 5th, 2025
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

WESTBROOK, Maine, June 5, 2025 /PRNewswire/ - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst(R) Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs.

Daily Guardian
Feb 17th, 2025
South Korea Flow Cytometry Industry Trends, Key Players & Future Outlook: Rising Healthcare & Biotech Investments Drive South Korea Flow Cytometry Market Growth

February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.

ETF Daily News
Dec 4th, 2024
Quantbot Technologies LP Makes New $341,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Quantbot Technologies LP makes new $341,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

Veterinary Practice News
Nov 12th, 2024
Industry partnership offers ACVIM residents free educational resources

The American College of Veterinary Internal Medicine (ACVIM) has partnered with IDEXX Laboratories, Inc. to endorse the SpringBoard program, offering complimentary, resident-focused educational resources.

MarketBeat
Oct 25th, 2024
Legacy Capital Group California Inc. Makes New $750,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Legacy Capital Group California Inc. makes new $750,000 investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

INACTIVE